Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 26, 2022
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
[ Fri, Aug 26th 2022
] - WOPRAI
Yasmeen Rahimi Initiated (VRNA) at Buy and Held Target at $31 on, Aug 26th, 2022
Yasmeen Rahimi of Piper Sandler, Initiated "Verona Pharma plc" (VRNA) at Buy and Held Target at $31 on, Aug 26th, 2022.
Yasmeen has made no other calls on VRNA in the last 4 months.
There is 1 other peer that has a rating on VRNA. Out of the 1 peers that are also analyzing VRNA, 0 agree with Yasmeen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yasmeen
- Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $18 on, Friday, June 17th, 2022
